AAAAAA

   
Results: 1-11 |
Results: 11
HIGH-DOSE METHOTREXATE (4-8 G M(2) 24 HR) IN CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA - A PILOT-STUDY 1980-1991/
Authors: MOE PJ SEIDEL H WESENBERG F STOKLAND T HAPNES C
Citation: Pj. Moe et al., HIGH-DOSE METHOTREXATE (4-8 G M(2) 24 HR) IN CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA - A PILOT-STUDY 1980-1991/, International journal of pediatric hematology/oncology, 5(2-4), 1998, pp. 155-162
INTENSIFIED TREATMENT OF ACUTE CHILDHOOD LYMPHOBLASTIC-LEUKEMIA HAS IMPROVED PROGNOSIS, ESPECIALLY IN NON-HIGH-RISK PATIENTS - THE NORDIC EXPERIENCE OF 2648 PATIENTS DIAGNOSED BETWEEN 1981 AND 1996
Authors: GUSTAFSSON G KREUGER A CLAUSEN N GARWICZ S KRISTINSSON J LIE SO MOE PJ PERKKIO M YSSING M SAARINENPIHKALA UM
Citation: G. Gustafsson et al., INTENSIFIED TREATMENT OF ACUTE CHILDHOOD LYMPHOBLASTIC-LEUKEMIA HAS IMPROVED PROGNOSIS, ESPECIALLY IN NON-HIGH-RISK PATIENTS - THE NORDIC EXPERIENCE OF 2648 PATIENTS DIAGNOSED BETWEEN 1981 AND 1996, Acta paediatrica, 87(11), 1998, pp. 1151-1161
LONG-TERM SURVIVAL AND QUALITY-OF-LIFE IN PATIENTS TREATED WITH A NATIONAL ALL PROTOCOL 15-20 YEARS EARLIER - IDM HDM AND LATE EFFECTS/
Authors: MOE PJ HOLEN A GLOMSTEIN A MADSEN B HELLEBOSTAD M STOKLAND T WEFRING KW STEENJOHNSEN J NIELSEN B HOWLID H BORSTING S HAPNES C
Citation: Pj. Moe et al., LONG-TERM SURVIVAL AND QUALITY-OF-LIFE IN PATIENTS TREATED WITH A NATIONAL ALL PROTOCOL 15-20 YEARS EARLIER - IDM HDM AND LATE EFFECTS/, Pediatric hematology and oncology, 14(6), 1997, pp. 513-524
CENTER-FOR-PEDIATRIC-HEMATOLOGY-AND-ONCOLOGY, UNIVERSITY-OF-TRONDHEIM, TRONDHEIM, NORWAY
Authors: MOE PJ
Citation: Pj. Moe, CENTER-FOR-PEDIATRIC-HEMATOLOGY-AND-ONCOLOGY, UNIVERSITY-OF-TRONDHEIM, TRONDHEIM, NORWAY, Pediatric hematology and oncology, 14(2), 1997, pp. 101-102
ON THE PROGNOSTIC VALUE OF SYSTEMIC METHOTREXATE CLEARANCE IN CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA
Authors: SEIDEL H NYGAARD R MOE PJ JACOBSEN G LINDQVIST B SLORDAL L
Citation: H. Seidel et al., ON THE PROGNOSTIC VALUE OF SYSTEMIC METHOTREXATE CLEARANCE IN CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA, Leukemia research, 21(5), 1997, pp. 429-434
METHOTREXATE AND ORAL MUCOSITIS
Authors: MOE PJ
Citation: Pj. Moe, METHOTREXATE AND ORAL MUCOSITIS, Pediatric hematology and oncology, 13(4), 1996, pp. 313-314
MAGNETIC-RESONANCE-IMAGING AND NEUROLOGICAL EVALUATION AFTER TREATMENT WITH HIGH-DOSE METHOTREXATE FOR ACUTE LYMPHOCYTIC-LEUKEMIA IN YOUNG-CHILDREN
Authors: SEIDEL H NYGAARD R HAAVE I MOE PJ
Citation: H. Seidel et al., MAGNETIC-RESONANCE-IMAGING AND NEUROLOGICAL EVALUATION AFTER TREATMENT WITH HIGH-DOSE METHOTREXATE FOR ACUTE LYMPHOCYTIC-LEUKEMIA IN YOUNG-CHILDREN, Acta paediatrica, 85(4), 1996, pp. 450-453
ENHANCEMENT OF ERYTHROPOIESIS BY ERYTHROPOIETIN, BOVINE PROTEIN AND ENERGY FORTIFIED MOTHERS MILK DURING ANEMIA OF PREMATURITY
Authors: RONNESTAD A MOE PJ BREIVIK N
Citation: A. Ronnestad et al., ENHANCEMENT OF ERYTHROPOIESIS BY ERYTHROPOIETIN, BOVINE PROTEIN AND ENERGY FORTIFIED MOTHERS MILK DURING ANEMIA OF PREMATURITY, Acta paediatrica, 84(7), 1995, pp. 809-811
EVALUATION OF SERIOUS ADVERSE EVENTS IN PATIENTS TREATED WITH PROTOCOLS INCLUDING METHOTREXATE INFUSIONS
Authors: SEIDEL H MOE PJ NYGAARD R NYGAARD K BREDE W BORSI JD
Citation: H. Seidel et al., EVALUATION OF SERIOUS ADVERSE EVENTS IN PATIENTS TREATED WITH PROTOCOLS INCLUDING METHOTREXATE INFUSIONS, Pediatric hematology and oncology, 11(2), 1994, pp. 165-172
CEREBRAL IRRADIATION CAUSES BLUNTED PUBERTAL GROWTH IN GIRLS TREATED FOR ACUTE-LEUKEMIA
Authors: MOELL C MARKY I HOVI L KRISTINSSON J RIX M MOE PJ GARWICZ S
Citation: C. Moell et al., CEREBRAL IRRADIATION CAUSES BLUNTED PUBERTAL GROWTH IN GIRLS TREATED FOR ACUTE-LEUKEMIA, Medical and pediatric oncology, 22(6), 1994, pp. 375-379
2ND MALIGNANT NEOPLASMS AFTER CANCER IN CHILDHOOD OR ADOLESCENCE
Authors: OLSEN JH GARWICZ S HERTZ H JONMUNDSSON G LANGMARK F LANNING M LIE SO MOE PJ MOLLER T SANKILA R TULINIUS H
Citation: Jh. Olsen et al., 2ND MALIGNANT NEOPLASMS AFTER CANCER IN CHILDHOOD OR ADOLESCENCE, BMJ. British medical journal, 307(6911), 1993, pp. 1030-1036
Risultati: 1-11 |